helping your business succeed
Through comprehensive and experienced business and legal support
helping your business succeed
Through comprehensive and experienced business and legal support
About Us
Strategic professionals with extensive US and global experience and proven success
KCG's founding partners leverage their 80+ years of global industry and consulting experiences supporting some of the world's largest and most successful products, companies and business deals. On a project-by-project basis, we leverage a broad range of extensively experienced cross-functional experts. Each KCG Project Team is formed independently at the start of an engagement and confirmed by clients during the project scoping process.
Value we bring to our clients
We have helped our clients in the bio-pharmaceutical, medical device, diagnostic, healthcare, legal, oil, consulting, and investment banking industries achieve success building new product strategies, identifying values and risks, improve decision making, complete in-license deals and raise investment capital. Our legal consulting on contracts, intellectual property and expert witness services has been critical to corporate mergers, investor communications, and international legal proceedings.
Why choose Kondrad Consulting Group?
Our mission is to work side-by-side with our clients and help them succeed with confidence. KCGs’ relatively low overhead, limited client engagements and focused expert Project Teams allow us to provide maximum return on value, with quality and speed of investment for our clients.
services available
New Product Development
Corporate and Business Development and Licensing Support
New Product Development
- R&D, CMC, clinical, regulatory, payer and commercialization strategy.
- Critical decision support through primary & secondary market research and competitive intelligence with health care professionals and payers to support payer, pricing, market access, and reimbursement strategies.
- Target Product Profile (TPP) development and commercial
- R&D, CMC, clinical, regulatory, payer and commercialization strategy.
- Critical decision support through primary & secondary market research and competitive intelligence with health care professionals and payers to support payer, pricing, market access, and reimbursement strategies.
- Target Product Profile (TPP) development and commercial value forecasts.
- Product launch and go-to-market strategies.
- Professional medical conference support and KOL engagements.
Legal Support
Corporate and Business Development and Licensing Support
New Product Development
- Patent and trademark strategy and communications to support licensing and strategic partnering activities.
- Business or new product contract assessment and negotiations including IP licensing agreements.
- Contract strategy support for acquisitions or divestment of products and technologies.
- Experienced expert witness support in multiple therapeutic and business areas.
NOTE: KCG is not a law firm.
Corporate and Business Development and Licensing Support
Corporate and Business Development and Licensing Support
Corporate and Business Development and Licensing Support
- New product opportunity identification and evaluation.
- Target Product Profile, commercial value, forecast and indicative terms
- Deal Team leadership.
- Partnering support & Communications for in- and out-licensing and M&A.
- Due Diligence leadership, preparation, training, and execution.
- Project management for technology transfer; clinical, commer
- New product opportunity identification and evaluation.
- Target Product Profile, commercial value, forecast and indicative terms
- Deal Team leadership.
- Partnering support & Communications for in- and out-licensing and M&A.
- Due Diligence leadership, preparation, training, and execution.
- Project management for technology transfer; clinical, commercial, pharmacovigilance, CMC and payer.
- Alliance Management with partners.
- Contract / Agreement assessment and negotiation.
leadership team experience
Frank Kondrad, Managing Partner
Frank is a seasoned biopharmaceutical executive with more than 45 years of global pharmaceutical leadership spanning corporate strategy, business development and licensing, drug development, commercialization, payer strategy, and regulatory operations. As Managing Partner of the Kondrad Consulting Group LLC, he advises biopharma and medical device companies on high-stakes growth initiatives, including licensing and partnership strategy, pricing and market access, CMC benchmarking and regulatory readiness, brand commercialization, physician, KOL, and payer market research, and expert legal witness support. His career reflects rare end-to-end expertise across the full product lifecycle—from early development through global launch, market access, and lifecycle optimization.
Frank has held senior leadership and advisory roles across emerging and established companies, including the virtual company incubator BusStim LLC, Epizon Pharma, NeuroBo Pharmaceuticals, and Shackelford Pharma, where he has led biotech acceleration initiatives, in-licensing transactions in obesity, MASH (NASH), diabetes, renal, pulmonary and neurology, and R&D program advancement in severe epilepsy. Over a distinguished 35-year tenure at AstraZeneca, he served in executive roles including Executive Director of Business Development & Licensing (CV, Metabolic & Renal), Senior Director of Neuroscience Clinical Development, Managed Markets Director, commercial and managed markets Brand Leader, Market Research director, International Strategic Planning Manager, and Head of Global CMC Project Management and Regulatory Documentation. He also led critical managed markets and commercial strategy projects and functions for major global brands—including NEXIUM, CRESTOR, and SEROQUEL—driving payer engagement and strategy, brand positioning, and cross-functional launch excellence while serving as a strategic interface with external medical, scientific, and policy leaders on emerging healthcare reform issues.
Frank holds an honors degree from Philadelphia College of Pharmacy & Science and has completed advanced graduate studies in pharmacology, business, strategy, finance, and leadership at Hahnemann Medical University, The Wharton School of the University of Pennsylvania, and INSEAD. He is an active member of leading professional organizations across licensing, managed care, liver disease, cardiology, market research, and project management, reflecting both his scientific depth and commercial acumen.A science-based business leader with a broad healthcare background. Frank has led projects in business strategy, new drug and device development, business development in/out-licensing, commercial brand and payer strategy, payer pricing research, strategic planning and CMC regulatory readiness. He excels at primary and secondary market research.
Karen Kondrad JD, Partner and General Counsel
Karen is a consulting intellectual property and contracts attorney with extensive global industry experience across life sciences and advanced energy technologies. She brings a broad and strategic background spanning due diligence, complex agreements, business development, licensing, intellectual property strategy, and the management of external counsel.
Karen has advised clients on corporate divestitures, contract reviews, IP strategy, and investor communications. She has led IP and commercial contract negotiations for multi-billion-dollar acquisitions and divestitures, including transactions involving commercial products, early- and late-stage R&D assets, and research collaborations with both industry and academic institutions. Her experience also includes leading successful inter partes review (IPR) proceedings, European patent challenges, global patent procurement and prosecution, licensing due diligence, and freedom-to-operate analyses.
Prior to her consulting work, Karen held senior legal and scientific roles at leading global organizations, including AstraZeneca, DuPont, DuPont-Merck, and GlaxoSmithKline. Her positions included Principal Patent Attorney for Business Development and Licensing, Senior Patent Attorney, Chief Trademark Counsel, Assistant General Counsel, and research Medicinal Chemist.
Karen holds a degree in chemistry with honors from the Philadelphia College of Pharmacy & Science and a law degree from Widener University Delaware Law School. She is admitted to practice in Pennsylvania and New Jersey, is registered before the U.S. Patent and Trademark Office, and is eligible under Delaware Rule 55.1. She is also actively engaged in leadership roles within her local community.